Table 2.

Selected immunogenic and antigenic peptides in the S and N proteins of SARS-CoV-2.

Epitope	Protein	Domain	Epitope sequence*	Epitope length	Position
1	S	S1	SQCVNLTT	8	13–20
2			RTQLPPAYTNS	11	21–31
3			GVYYPDKVF	9	35–43
4			SNVTWFHAIHVSGTNGTKRF	20	60–79
5			FLGVYYHKNNKSWME	15	140–154
6			MESEFRVYSSANN	13	153–165
7			INLVRDLPQGFSA	13	210–222
8			LTPGDSSSGWTAG	13	249–261
9			VRQIAPGQTGKIAD	14	407–420
10			SNNLDSKVGGNYNYLY	15	438–453
11			RLFRKSNLKPFERD	14	454–467
12			ISTEIYQAGSTPCNGVEGF	19	468–486
13			YGFQPTNGVGYQ	12	495–506
14			GPKKSTNLVKNK	12	526–537
15			RDIADTTDAVRDPQ	14	567–580
16	S	S2	QTQTNSPRRARSV	13	675–687
17			ILPDPSKPSKRS	12	805–816
18			VPAQEKNFTT	10	1068–1077
19			FDEDDSEPVL	10	1256–1265
20	N		MSDNGPQNQRNAPRIT	16	1–16
21			AALALLLLDRL	11	217–227
22			KHWPQIAQFAPSASAFF	17	299–315
23			RIRGGDGKMKDL	12	93–104
24			SPRWYFYYLG	10	105–114
25			ILLNKHIDAYKT	12	351–362

*In bold: peptides selected for MAP8 synthesis.